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Objectives: to compare arm and saphenous veins for infrageniculate bypass grafting.
Design: prospective non-randomised study.
Materials: two hundred patients, of which 197 had ischaemic tissue loss or rest pain.
Methods: two hundred and eleven infrageniculate vein bypass procedures using 176 greater saphenous veins and 35
arm veins.
Results: the cumulative primary graft patency rate at 1-month and 2 years was 80% and 61% for saphenous vein and
89% and 42% for arm vein. The corresponding rates for secondary patency were 84.5% and 68%, and 91% and 57%,
respectively. These results corresponded to a relative risk of secondary failure of 1.53 (95% CI 0.71, 3.31) for arm vein
grafts. In subgroup analyses, this estimate was 0.93 and 2.1 for primary vs secondary bypasses and 0.38 and 2.06 for
single-vein vs spliced-vein bypasses. Among arm veins, cephalic vein grafts performed better than basilic vein grafts.
Early mortality was 14% for arm vein and 10% for saphenous vein.
Conclusion: in the setting of infrageniculate bypass grafting, arm vein grafts are not equivalent to greater saphenous
vein grafts, but contribute importantly to a policy of using autologous veins. The possibility of equivalence remains for
the arm vein graft that uses a cephalic vein or is a primary procedure.
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Introduction lower incidence of graft failure for alternative veins
(mostly AVs) compared with contralateral GSVs. This
The use of an arm vein (AV) for infrainguinal arterial was so in spite of these authors’ preference for the
contralateral GSV alternative. In the present pro-reconstruction was first reported by Kakkar in 1969,1
but interest in this technique2,3 did not increase until spective study, AVs and GSVs were compared to deter-
mine their relative merits as bypass grafts to thethe limitations of prosthetic graft material became
established.4,5 When the ipsilateral greater saphenous infrageniculate arteries.
vein (GSV) is unsuitable, some surgeons harvest the
contralateral GSV,6,7 whereas others resort to AV.8 De- Material and Methods
spite the disagreement on the preferred strategy, the
renewed interest in AV grafts as part of a policy for Patients
the maximal utilisation of autologous tissue has led
to improvements in reconstructive techniques8–11 and The compared series were well balanced at baseline for
to better results in large surgical series.2,12,13 most demographic variables, risk factors for peripheral
Although there are no biological grounds for as- arterial disease, and important clinical variables, but
suming the supremacy of any ex situ autologous vein there was a severe imbalance for previous bypass
as a conduit, the superiority of GSVs in terms of (Table 1).
graft patency has rarely been challenged.14 In a recent
retrospective study, however, Gentile et al.7 found a Study design
In a prospective series of autologous vein bypass grafts∗ Please address all correspondence to: M. Albers, Rua Ministro
Godo´i, 1584, AP 74, ZIP 05015-001 Sa˜o Paulo, Brazil. to an infrageniculate artery, AV grafts were compared
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Table 1. Differences at baseline between the study groups. Assembling the cohorts
AV grafts GSV grafts
(n=35) (n=176) Ethical principles guided patient allocation to one of
the two study groups.16 This meant that an AV bypass
Female sex (%) 14 (40) 70 (40) graft was done only when a GSV was absent, hadMedian age 66 69
Diabetes (%) 26 (74) 109 (62) obvious pre-existing disease, or would be better
Smoking (%) 16 (46) 75 (43) spared. Prosthetic and allograft bypasses were not
Heart disease (%) 15 (43) 74 (42) considered for inclusion and the following entry cri-Surgical indication
Claudication (%) 0 (0) 2 (1) teria were adopted: (1) the presence of ischaemic rest
Rest pain (%) 7 (20) 17 (10) pain, non-healing ulceration, gangrene, disabling clau-
Skin lesion (%) 27 (77) 157 (89) dication or a failing graft, (2) palpable femoral butFailing graft (%) 1 (3) 0 (0)
ABI <0.5 (%) 26 (75) 123 (70) absent pedal pulses or the diagnosis of a failing graft,
Infrapopliteal bypass (%) 24 (69) 123 (70) and (3) the use of either a GSV or an AV in a bypass
Previous infrainguinal bypass (%) 16 (46) 5 (3) inserted in the below-knee popliteal artery or more
ABI is the ankle–brachial systolic blood pressure index and was distally.
measured before 24 AV grafts and 142 GSV grafts. Absent pedal pulses suggested, but was insufficient
to determine, the presence and extent of arterial oc-
clusion. An ankle–brachial systolic blood pressure
index (ABI) of less than 0.5 indicated arterial occlusion
in 117 extremities. Preoperative arteriography con-
to GSV grafts. A graft was included in the AV cohort firmed this diagnosis and showed the extent of oc-
if most of it consisted of an AV, whereas a graft in the clusion in 113 instances, but was not obtained for four
GSV cohort consisted of a GSV alone or in combination extremities, all of which with an ABI of less than
with a smaller segment of another autologous vessel 0.3. Preoperative arteriography was also done in 48
of the lower limb. Primary and secondary graft failures extremities with an ABI equal to or greater than 0.5,
as strictly defined elsewhere were the end-points of and 45 extremities in which the ABI was not measured.
prime interest,15 but major amputation, death, and the In the remaining extremity, a popliteal-to-plantar by-
need for non-autologous grafts were also assessed. pass was performed without the assistance of ABI or
The rationale for subgroup analyses was that (1) arteriography.
a former arterial reconstruction in the affected limb The Institutional Review Board approved the al-
negatively influences graft patency of a subsequent location procedure and the study protocol. From Jan-
bypass,6 (2) the construction of spliced-vein grafts is uary 1991 to the end of December 1995, 35 AV grafts
potentially more aggressive to vein integrity, and (3) and 176 GSV grafts were done consecutively in 200
cephalic and basilic veins differ in length, uniformity patients at two tertiary referral centres and one private
of diameter, and rates of use in bypass surgery.2,3,8 hospital. Other six prosthetic bypasses and 24 allograft
Subgroups determined by the ordering of operation, vein bypasses were not considered for inclusion. In-
number of venous segments used, and source of vein dication for surgery is given in Table 1. The reasons
were also analysed. Considering the target limb, a for not using a GSV included previous arterial re-
primary graft (n=177) was the first bypass performed, construction (21 in the same and seven in the other
while a secondary graft (n=34) was a bypass per- leg), previous vein stripping (four in the same and
formed subsequent to any previous infrainguinal re- three in the other leg), vein inadequacies (10 in the
construction. A single-vein graft (n=188) used only same and six in the other leg), and contralateral major
one vein segment while a spliced composite vein graft amputations in six patients. The absence of peripheral
(n=23) included at least two spliced venous segments pulses or the presence of severe ischaemia made har-
or a venous segment spliced to a segment of en- vesting of the GSV in the contralateral leg inadvisable
darterectomised femoral artery. Either combined or in 13 instances.
not to a vessel of the lower limb, the cephalic AV
grafts (n=20) used cephalic but not basilic veins while
the basilic AV grafts (n=15) used a basilic vein com- Surgical techniques
bined or not to a cephalic vein.
The date of grafting was adopted as zero time for When the use of an AV graft was foreseen, one of the
upper limbs was chosen and bandaged as a safeguardthe follow-up and the unit of analysis was the first
infrageniculate vein bypass performed in the index against possible venipunctures. The skin over the se-
lected vein was marked with black ink on the daylimb during the study.
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Table 2. Level of arterial anastomoses. Grafts using spliced veins or segments of autologous artery are shown between parentheses
and secondary grafts are shown between brackets.
Distal anastomosis
Proximal anastomosis Previous Popliteal Tibial/ Pedal
bypass peroneal
AV grafts
Previous bypass 1 2 (2)[2] 2 (1)[2] 1 [1]
External iliac 1 [1] 2 (1)[2]
Common femoral 6 (1)[1] 3 (2)[2] 1 (1)
Superficial femoral 1 [1] 5 (1)[5] 2 (2)[1]
Popliteal 3 (1)[2]
GSV grafts
Previous bypass 3 [3] 2 [2]
External iliac 1 2 (1)[1]
Common femoral 26 [1] 31 (1)[2] 2 (1)
Superficial femoral 21 (3)[1] 44 (3)[2] 11 (1)
Profunda femoris 2 [2]
Popliteal 14 (1) 15
Tibial 2
before surgery, but on rare occasions the decision Follow-up
about which vein to harvest was deterred until surgical
Patients were reassessed every 4 months according toexploration. Since two surgical teams worked sim-
an active plan that included home visits when neces-ultaneously, one on the upper limb and the other
sary. A time period of over 12 months with no assess-on the lower limb, general anaesthesia was mostly
ment of graft patency was defined as loss to follow-preferred. A long skin incision enhanced vein har-
up. By this criterion, 22 grafts were lost. Of these,vesting in the upper limb, but GSVs were harvested
15 grafts did not complete a one-year follow-up. Inthrough three or more interrupted skin incisions. Since
addition to palpating pulses over the graft and in theAVs are thin-walled, their small tributaries must be
foot, Doppler ultrasound pressures were measuredhandled with great care as avulsions are not rare and
routinely to assess graft patency. Duplex-scanning andstumps must be kept longer than 2 mm to allow proper
arteriography were used only when arterial pulsesligation and the introduction of valvulotomes. The
became weak or a fall of 0.15 or more was found inblood flow into the selected vein was maintained for
the ABI.as long as possible and desiccation was avoided by
using surgical pads moistened in saline. These tech-
nical aspects have all been appropriately stressed by
others.2,17 Statistics
The proximal anastomosis was usually constructed
first to take advantage of vein dilation under arterial Long-term results were described by the Kaplan–Meier
pressure2,18,19 and most grafts ended in an infrapopliteal product-limit method,21 but the relative risk of graft
artery (Table 2). AV grafts included 23 single-vein failure was estimated using the Mantel–Haenszel pro-
conduits, but 12 composite conduits were needed. The cedure to provide a uniform approach for all the
former were done with three reversed cephalic veins comparisons.22 A 95% confidence interval was cal-
and 20 (12 cephalic, five basilic, and three combined culated using the Miettinen formula for the observed
cephalic-basilic) veins used as non-reversed grafts. relative risk. Since patency curves for AV grafts and
Spliced composite AV grafts were constructed with a GSV grafts crossed, the assumption of proportional
cephalic vein in five instances, a basilic vein in two, hazards was not verified. Therefore, the log-rank test
and with both sources of vein in five. There were 98 would not apply to the entire follow-up and the Cox
non-reversed, 67 reversed, and 11 composite grafts in model was not warranted.
the GSV cohort. Additional graft material in the GSV A two-factor sensitivity analysis was done under
composite conduits consisted of six endarterectomised two assumptions. First, the difference in the one-month
arteries,20 three accessory saphenous veins, and two graft patency rate between the preferred, non-reversed
GSV grafts and the reversed GSV grafts should notlesser saphenous veins.
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Fig. 1. Kaplan–Meier estimates for secondary graft patency. Dotted Fig. 2. Kaplan–Meier estimates for foot salvage. Dotted lines in-
dicated 1 SD >10% (—) AV group; ( ) GSV group.lines indicated 1 SD >10%. The numbers indicate the number of
patients under observation (—) AV grafts; ( ) GSV grafts.
Foot salvage
exceed 5%. This assumption implied decreasing the
number of early failed grafts of the latter type from Loss of the foot was the result of graft occlusion (seven
17 to eight. Second, up to 60% of the grafts lost to AV and 22 GSV) or extensive tissue damage despite a
follow-up within 12-months were assumed to have patent graft (two AV, and 10 GSV) and included 20
failed.23 Degrees of correction of 50% and 100% were (three AV and 17 GSV) below-knee as well as 21
applied simultaneously to both factors. (six AV, and 15 GSV) above-knee amputations. The
cumulative foot salvage rate at 1 month, 1 year, and
4 years was 94%, 79%, and 57% for AV grafts and 88%,
81%, and 81% for GSV grafts, respectively (Fig. 2).Results
Graft patency
Patient survival
The primary graft patency rate at 36 months was 42%
and 61% respectively, for AV grafts and GSV grafts Eleven AV patients and 63 GSV patients died during
the study. Their deaths were attributed to cardio-(n.s.). The secondary graft patency rates at 12 and 36
months were 62% and 57% for AV grafts and 76% vascular events (four AV and 34 GSV), septic com-
plications (four AV and 17 GSV), renal failure (fourand 68% for GSV grafts (n.s.), respectively (Fig. 1).
Secondary analyses for some surgical covariates are GSV), cancer (two AV and one GSV), pulmonary em-
bolism (one AV and three GSV), bleeding disordersshown in Table 3.
Table 3. Relative risks of graft failure.
Group Failed Graft- RR 95% CI 2 p-value
size grafts months
All grafts
GSV 176 45 2546 1.00
AV 35 11 406 1.53 0.71, 3.31 2.17 0.14
Cephalic AV 20 5 289 0.98 0.78, 1.22 0.03 0.85
Basilic AV 15 6 117 2.90 1.14, 7.41 8.47 0.004
Primary grafts
GSV 171 43 2450 1.00
AV 19 4 246 0.93 0.23, 3.75 0.01 0.91
Secondary grafts
GSV 5 2 96 1.00
AV 16 7 160 2.1 0.68, 6.48 1.67 0.20
Single-vein grafts
GSV 165 41 2458 1.00
AV 23 8 233 2.06 1.07, 3.96 4.68 0.03
Spliced-vein grafts
GSV 11 4 88 1.00
AV 12 3 173 0.38 0.05, 3.03 0.83 0.36
RR is the relative risk, and 95% CI is the 95% confidence interval.
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(one GSV), and unknown causes (five GSV). The cumu- veins and fewer basilic AV grafts were primary bypass
procedures. In addition, AV grafts using basilic andlative patient survival rate at 1 month, 1 year, and 4
years was 86%, 73%, and 62% for AV grafts and 90%, cephalic vein segments spliced together, clearly a sub-
set of grafts at higher risk, were arbitrarily included79%, and 47% for GSV grafts, respectively.
in the basilic AV subgroup.
The subset of primary AV grafts performed as well
as the much larger subgroup of primary GSV grafts
Sensitivity analyses and the observed relative risk was barely responsive
to extreme variation at sensitivity analysis. AV grafts
In the comparison of primary AV grafts and primary definitely performed worse than GSV grafts in re-
GSV grafts, the relative risk of AV graft failure in- operations, thus contributing to the increased overall
creased from 0.93 to 0.98 (50% correction) and 1.11 risk of AV graft failure (Table 3).
(100% correction). When comparing cephalic AV grafts As a non-randomised concurrent cohort com-
and GSV grafts, the corresponding estimate of 0.98 parison, this study was level three evidence33 and the
increased to 0.99 and 1.01 with corrections of 50% and results of the subgroup analyses were useful in-
100%, respectively. formation.34 Level two evidence incorporates ran-
domisation and is thus theoretically superior, but the
random allocation of patients who have a usable GSV
to receive an AV bypass would hardly be ethical.
Discussion Furthermore, the enrolment of 888 patients is required
when using probabilities of 0.10 and 0.30 for statistical
The policy of using AV grafts in this series increased errors (one-tailed comparison in an equivalence trial
the use of totally autologous bypasses from 73% to of low power), a cumulative event rate of 32% in the
89%. The overall comparison between AV grafts and control group, and a relative risk of 1.1.35 In the absence
GSV grafts was biased by design because the stringent of such a trial, a meta-analysis of individual patients
inclusion criteria made the AV group a more dis- becomes attractive, but the difficulties in obtaining full
advantageous one in which the prevalence of previous adherence to this idea should not be underestimated.36
bypass at baseline was much higher. A second source In a broad perspective, this study may be perceived
of bias was the preferential use of cephalic veins over as a contribution to a global effort, rather than a one-
basilic veins and the higher proportion of both spliced step route to an answer.34 The present results confirmed
veins and non-reversed veins in the AV group. Our the prevailing opinion that AV grafts contribute im-
preference for non-reversed conduits, which relies on portantly to a policy of bypass grafting using
better size match at the anastomoses, allowance for autologous veins. As a whole such grafts are not
reverse flow within the graft, and vein dilation with equivalent to GSV grafts as infrageniculate bypasses,
normothermic blood under arterial blood pressure, but the possibility of equivalence remains for the
has been reported.20,24–26 Subgroup analyses completed AV graft that uses a cephalic vein or is a primary
by a sensitivity analysis were useful for dealing with procedure.
such overt biases.
The 4-year patency rate for cephalic AV grafts was
identical to the estimate reported by Harris et al.2
In the GSV cohort, the corresponding estimate was
superior to the rates reported for other consecutive
Referencesseries,27–29 but did not reach the higher figures obtained
in some modern series.7,30,31 Despite low precision, the 1 Kakkar VV. The cephalic vein as a peripheral vascular graft.
Surg Gynec Obstet 1969; 128: 551–556.point estimate for the relative risk suggested clinical
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